Products	O
,	O
By	O
Product	O
Category	O
Artificial	O
Urinary	O
Sphincter	O
Access	O
Device	O
:	O
Dilatation	O
Access	O
Device	O
:	O
Sheath	O
Accessories	O
Balloons	O
:	O
Dilation	O
and	O
Extraction	O
Band	O
Ligator	O
Baskets	O
View	O
All	O
Resources	O
&	O
Support	O
Customer	O
Support	O
Product	O
Details	O
Scan	O
App	O
Reimbursement	O
By	O
Medical	O
Specialty	O
Electrophysiology	O
Products	O
,	O
Female	O
Pelvic	O
Medicine	O
Products	O
,	O
Gastroenterology	O
Products	O
,	O
Gynecology	O
Products	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Products	O
,	O
Interventional	O
Radiology	O
Products	O
,	O
Neurological	O
Surgery	O
Products	O
,	O
Orthopedic	O
Surgery	O
Products	O
,	O
Pain	O
Medicine	O
Products	O
,	O
Pulmonology	O
Products	O
,	O
Urology	O
Products	O
,	O
Vascular	O
Surgery	O
Products	O
,	O
Get	O
Product	O
Info	O
Stat	O
Access	O
product	O
information	O
quickly	O
and	O
easily	O
with	O
our	O
mobile	O
app	O
Get	O
the	O
Free	O
App	O
Get	O
Product	O
Info	O
Stat	O
Access	O
product	O
information	O
quickly	O
and	O
easily	O
with	O
our	O
mobile	O
app	O
Get	O
the	O
Free	O
App	O
,	O
Products	O
,	O
By	O
Product	O
Category	O
Artificial	O
Urinary	O
Sphincter	O
Access	O
Device	O
:	O
Dilatation	O
Access	O
Device	O
:	O
Sheath	O
Accessories	O
Balloons	O
:	O
Dilation	O
and	O
Extraction	O
Band	O
Ligator	O
Baskets	O
Products	O
,	O
Resources	O
&	O
Support	O
Customer	O
Support	O
Product	O
Details	O
Scan	O
App	O
Reimbursement	O
By	O
Medical	O
Specialty	O
Electrophysiology	O
Products	O
,	O
Female	O
Pelvic	O
Medicine	O
Products	O
,	O
Gastroenterology	O
Products	O
,	O
Gynecology	O
Products	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Products	O
,	O
Interventional	O
Radiology	O
Products	O
,	O
Neurological	O
Surgery	O
Products	O
,	O
Orthopedic	O
Surgery	O
Products	O
,	O
Pain	O
Medicine	O
Products	O
,	O
Pulmonology	O
Products	O
,	O
Urology	O
Products	O
,	O
Vascular	O
Surgery	O
Products	O
,	O
Get	O
Product	O
Info	O
Stat	O
Access	O
product	O
information	O
quickly	O
and	O
easily	O
with	O
our	O
mobile	O
app	O
Get	O
the	O
Free	O
App	O
Get	O
Product	O
Info	O
Stat	O
Access	O
product	O
information	O
quickly	O
and	O
easily	O
with	O
our	O
mobile	O
app	O
Get	O
the	O
Free	O
App	O
,	O
Professionals	O
Medical	O
Specialties	O
Electrophysiology	O
Female	O
Pelvic	O
Medicine	O
Gastroenterology	O
Gynecology	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Interventional	O
Radiology	O
Neurological	O
Surgery	O
Orthopedic	O
Surgery	O
Pain	O
Medicine	O
Pulmonology	O
Urology	O
Vascular	O
Surgery	O
Professional	O
Resources	O
Education	O
Reimbursement	O
Investigator-Sponsored	O
Research	O
Program	O
Customer	O
Support	O
Customer	O
Support	O
Contact	O
Us	O
By	O
Email	O
Elevate	O
Your	O
Education	O
Explore	O
Educare	O
,	O
our	O
globally	O
recognized	O
education	O
program	O
Learn	O
More	O
Patients	O
Breathing	O
&	O
Lungs	O
Asthma	O
Cancer	O
Colon	O
Cancer	O
Pancreatic	O
Cancer	O
Digestive	O
&	O
Nutrition	O
Enteral	O
Feeding	O
Heart	O
Arrhythmias	O
/	O
Abnormal	O
Heartbeat	O
Atrial	O
Arrhythmias	O
Atrial	O
Fibrillation	O
Bradycardia	O
Long	O
QT	O
Syndrome	O
Ventricular	O
Arrhythmias	O
Heart	O
&	O
Blood	O
Vessels	O
Cardiomyopathy	O
Congenital	O
Heart	O
Disease	O
Coronary	O
Artery	O
Disease	O
Deep	O
Vein	O
Thrombosis	O
Heart	O
Attack	O
Heart	O
Failure	O
Peripheral	O
Artery	O
Disease	O
Sudden	O
Cardiac	O
Arrest	O
Kidneys	O
Kidney	O
Stones	O
Men	O
's	O
Health	O
Bladder	O
Leakage	O
Enlarged	O
Prostate	O
Erectile	O
Dysfunction	O
Pain	O
Management	O
Chronic	O
Pain	O
Women	O
's	O
Health	O
Heavy	O
Menstrual	O
Bleeding	O
Stress	O
Urinary	O
Incontinence	O
Uterine	O
Fibroids	O
and	O
Polyps	O
Patient	O
Support	O
Patient	O
and	O
Caregiver	O
Support	O
We	O
're	O
Here	O
to	O
Help	O
Our	O
customer	O
support	O
team	O
is	O
happy	O
to	O
answer	O
your	O
questions	O
Get	O
in	O
Touch	O
Products	O
By	O
Product	O
Category	O
Artificial	O
Urinary	O
Sphincter	O
Access	O
Device	O
:	O
Dilatation	O
Access	O
Device	O
:	O
Sheath	O
Accessories	O
Balloons	O
:	O
Dilation	O
and	O
Extraction	O
Band	O
Ligator	O
Baskets	O
Products	O
Resources	O
&	O
Support	O
Customer	O
Support	O
Product	O
Details	O
Scan	O
App	O
Reimbursement	O
By	O
Medical	O
Specialty	O
Electrophysiology	O
Products	O
Female	O
Pelvic	O
Medicine	O
Products	O
Gastroenterology	O
Products	O
Gynecology	O
Products	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Products	O
Interventional	O
Radiology	O
Products	O
Neurological	O
Surgery	O
Products	O
Orthopedic	O
Surgery	O
Products	O
Pain	O
Medicine	O
Products	O
Pulmonology	O
Products	O
Urology	O
Products	O
Vascular	O
Surgery	O
Products	O
Get	O
Product	O
Info	O
Stat	O
Access	O
product	O
information	O
quickly	O
and	O
easily	O
with	O
our	O
mobile	O
app	O
Get	O
the	O
Free	O
App	O
About	O
About	O
Who	O
We	O
Are	O
Businesses	O
Leadership	O
Locations	O
History	O
Citizenship	O
Corporate	O
Citizenship	O
Community	O
Involvement	O
Sustainability	O
Giving	O
Compliance	O
&	O
Ethics	O
Policy	O
&	O
Advocacy	O
Careers	O
Careers	O
Working	O
Here	O
Explore	O
Careers	O
Students	O
Community	O
Involvement	O
Fueling	O
the	O
next	O
generation	O
of	O
life	O
science	O
professionals	O
Boston	O
Scientific	O
and	O
STEM	O
USA	O
,	O
News	O
Careers	O
Investors	O
USA	O
Professionals	O
Medical	O
Specialties	O
Electrophysiology	O
Female	O
Pelvic	O
Medicine	O
Gastroenterology	O
Gynecology	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Interventional	O
Radiology	O
Neurological	O
Surgery	O
Orthopedic	O
Surgery	O
Pain	O
Medicine	O
Pulmonology	O
Urology	O
Vascular	O
Surgery	O
Professional	O
Resources	O
Education	O
Reimbursement	O
Investigator-Sponsored	O
Research	O
Program	O
Customer	O
Support	O
Customer	O
Support	O
Contact	O
Us	O
By	O
Email	O
Elevate	O
Your	O
Education	O
Explore	O
Educare	O
,	O
our	O
globally	O
recognized	O
education	O
program	O
Learn	O
More	O
Patients	O
Breathing	O
&	O
Lungs	O
Asthma	O
Cancer	O
Colon	O
Cancer	O
Pancreatic	O
Cancer	O
Digestive	O
&	O
Nutrition	O
Enteral	O
Feeding	O
Heart	O
Arrhythmias	O
/	O
Abnormal	O
Heartbeat	O
Atrial	O
Arrhythmias	O
Atrial	O
Fibrillation	O
Bradycardia	O
Long	O
QT	O
Syndrome	O
Ventricular	O
Arrhythmias	O
Heart	O
&	O
Blood	O
Vessels	O
Cardiomyopathy	O
Congenital	O
Heart	O
Disease	O
Coronary	O
Artery	O
Disease	O
Deep	O
Vein	O
Thrombosis	O
Heart	O
Attack	O
Heart	O
Failure	O
Peripheral	O
Artery	O
Disease	O
Sudden	O
Cardiac	O
Arrest	O
Kidneys	O
Kidney	O
Stones	O
Men	O
's	O
Health	O
Bladder	O
Leakage	O
Enlarged	O
Prostate	O
Erectile	O
Dysfunction	O
Pain	O
Management	O
Chronic	O
Pain	O
Women	O
's	O
Health	O
Heavy	O
Menstrual	O
Bleeding	O
Stress	O
Urinary	O
Incontinence	O
Uterine	O
Fibroids	O
and	O
Polyps	O
Patient	O
Support	O
Patient	O
and	O
Caregiver	O
Support	O
We	O
're	O
Here	O
to	O
Help	O
Our	O
customer	O
support	O
team	O
is	O
happy	O
to	O
answer	O
your	O
questions	O
Get	O
in	O
Touch	O
Products	O
By	O
Product	O
Category	O
Artificial	O
Urinary	O
Sphincter	O
Access	O
Device	O
:	O
Dilatation	O
Access	O
Device	O
:	O
Sheath	O
Accessories	O
Balloons	O
:	O
Dilation	O
and	O
Extraction	O
Band	O
Ligator	O
Baskets	O
View	O
All	O
Resources	O
&	O
Support	O
Customer	O
Support	O
Product	O
Details	O
Scan	O
App	O
Reimbursement	O
By	O
Medical	O
Specialty	O
Electrophysiology	O
Products	O
Female	O
Pelvic	O
Medicine	O
Products	O
Gastroenterology	O
Products	O
Gynecology	O
Products	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Products	O
Interventional	O
Radiology	O
Products	O
Neurological	O
Surgery	O
Products	O
Orthopedic	O
Surgery	O
Products	O
Pain	O
Medicine	O
Products	O
Pulmonology	O
Products	O
Urology	O
Products	O
Vascular	O
Surgery	O
Products	O
Get	O
Product	O
Info	O
Stat	O
Access	O
product	O
information	O
quickly	O
and	O
easily	O
with	O
our	O
mobile	O
app	O
Get	O
the	O
Free	O
App	O
About	O
About	O
Who	O
We	O
Are	O
Businesses	O
Leadership	O
Locations	O
History	O
Citizenship	O
Corporate	O
Citizenship	O
Community	O
Involvement	O
Sustainability	O
Giving	O
Compliance	O
&	O
Ethics	O
Policy	O
&	O
Advocacy	O
Careers	O
Careers	O
Working	O
Here	O
Explore	O
Careers	O
Students	O
Community	O
Involvement	O
Fueling	O
the	O
next	O
generation	O
of	O
life	O
science	O
professionals	O
Boston	O
Scientific	O
and	O
STEM	O
Sign	O
up	O
for	O
emails	O
Professionals	O
Medical	O
Specialties	O
Reimbursement	O
Education	O
Products	O
Products	O
Customer	O
Support	O
Patients	O
Health	O
Conditions	O
About	O
Corporate	O
Citizenship	O
Careers	O
Change	O
Country	O
USA	O
Professionals	O
Medical	O
Specialties	O
Electrophysiology	O
Female	O
Pelvic	O
Medicine	O
Gastroenterology	O
Gynecology	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Interventional	O
Radiology	O
Neurological	O
Surgery	O
Orthopedic	O
Surgery	O
Pain	O
Medicine	O
Pulmonology	O
Urology	O
Vascular	O
Surgery	O
Professional	O
Resources	O
Education	O
Reimbursement	O
Investigator-Sponsored	O
Research	O
Program	O
Customer	O
Support	O
Customer	O
Support	O
Contact	O
Us	O
By	O
Email	O
Elevate	O
Your	O
Education	O
Explore	O
Educare	O
,	O
our	O
globally	O
recognized	O
education	O
program	O
Learn	O
More	O
Patients	O
Breathing	O
&	O
Lungs	O
Asthma	O
Cancer	O
Colon	O
Cancer	O
Pancreatic	O
Cancer	O
Digestive	O
&	O
Nutrition	O
Enteral	O
Feeding	O
Heart	O
Arrhythmias	O
/	O
Abnormal	O
Heartbeat	O
Atrial	O
Arrhythmias	O
Atrial	O
Fibrillation	O
Bradycardia	O
Long	O
QT	O
Syndrome	O
Ventricular	O
Arrhythmias	O
Heart	O
&	O
Blood	O
Vessels	O
Cardiomyopathy	O
Congenital	O
Heart	O
Disease	O
Coronary	O
Artery	O
Disease	O
Deep	O
Vein	O
Thrombosis	O
Heart	O
Attack	O
Heart	O
Failure	O
Peripheral	O
Artery	O
Disease	O
Sudden	O
Cardiac	O
Arrest	O
Kidneys	O
Kidney	O
Stones	O
Men	O
's	O
Health	O
Bladder	O
Leakage	O
Enlarged	O
Prostate	O
Erectile	O
Dysfunction	O
Pain	O
Management	O
Chronic	O
Pain	O
Women	O
's	O
Health	O
Heavy	O
Menstrual	O
Bleeding	O
Stress	O
Urinary	O
Incontinence	O
Uterine	O
Fibroids	O
and	O
Polyps	O
Patient	O
Support	O
Patient	O
and	O
Caregiver	O
Support	O
We	O
're	O
Here	O
to	O
Help	O
Our	O
customer	O
support	O
team	O
is	O
happy	O
to	O
answer	O
your	O
questions	O
Get	O
in	O
Touch	O
Products	O
By	O
Product	O
Category	O
Artificial	O
Urinary	O
Sphincter	O
Access	O
Device	O
:	O
Dilatation	O
Access	O
Device	O
:	O
Sheath	O
Accessories	O
Balloons	O
:	O
Dilation	O
and	O
Extraction	O
Band	O
Ligator	O
Baskets	O
Products	O
Resources	O
&	O
Support	O
Customer	O
Support	O
Product	O
Details	O
Scan	O
App	O
Reimbursement	O
By	O
Medical	O
Specialty	O
Electrophysiology	O
Products	O
Female	O
Pelvic	O
Medicine	O
Products	O
Gastroenterology	O
Products	O
Gynecology	O
Products	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Products	O
Interventional	O
Radiology	O
Products	O
Neurological	O
Surgery	O
Products	O
Orthopedic	O
Surgery	O
Products	O
Pain	O
Medicine	O
Products	O
Pulmonology	O
Products	O
Urology	O
Products	O
Vascular	O
Surgery	O
Products	O
Get	O
Product	O
Info	O
Stat	O
Access	O
product	O
information	O
quickly	O
and	O
easily	O
with	O
our	O
mobile	O
app	O
Get	O
the	O
Free	O
App	O
About	O
About	O
Who	O
We	O
Are	O
Businesses	O
Leadership	O
Locations	O
History	O
Citizenship	O
Corporate	O
Citizenship	O
Community	O
Involvement	O
Sustainability	O
Giving	O
Compliance	O
&	O
Ethics	O
Policy	O
&	O
Advocacy	O
Careers	O
Careers	O
Working	O
Here	O
Explore	O
Careers	O
Students	O
Community	O
Involvement	O
Fueling	O
the	O
next	O
generation	O
of	O
life	O
science	O
professionals	O
Boston	O
Scientific	O
and	O
STEM	O
USA	O
Choose	O
your	O
Country	O
or	O
Region	O
USA	O
Australia-NZ	O
Brazil	O
China	O
Europe	O
India	O
Japan	O
Korea	O
Malaysia	O
United	O
States	O
Need	O
Help	O
?	O
Contact	O
Us	O
,	O
About	O
Who	O
We	O
Are	O
Businesses	O
Leadership	O
Locations	O
History	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
Boston	O
Scientific	O
is	O
dedicated	O
to	O
transforming	O
lives	O
through	O
innovative	O
medical	O
solutions	O
that	O
improve	O
the	O
health	O
of	O
patients	O
around	O
the	O
world	O
.	O
Boston	O
Scientific	O
is	O
dedicated	O
to	O
transforming	O
lives	O
through	O
innovative	O
medical	O
solutions	O
that	O
improve	O
the	O
health	O
of	O
patients	O
around	O
the	O
world	O
.	O
Professionals	O
Medical	O
Specialties	O
Reimbursement	O
Education	O
Patients	O
Health	O
Conditions	O
Patient	O
and	O
Caregiver	O
Support	O
Products	O
Products	O
Customer	O
Support	O
About	O
Who	O
We	O
Are	O
Corporate	O
Citizenship	O
Careers	O
©	O
2016	O
Boston	O
Scientific	O
Corporation	O
or	O
its	O
affiliates	O
.	O
All	O
rights	O
reserved	O
.	O
Privacy	O
Policy	O
Terms	O
of	O
Use	O
Copyright	O
Notice	O
Site	O
Map	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders.	O
,	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
,	O
Executive	O
Committee	O
,	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
,	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
,	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
,	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
,	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
,	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
,	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
,	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
,	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
,	O
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
,	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
,	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
,	O
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
,	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
,	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
,	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
,	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
,	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
,	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
,	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
,	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
NELDA	O
J.	O
CONNORS	O
,	O
CHARLES	O
J.	O
DOCKENDORFF	O
,	O
YOSHIAKI	O
FUJIMORI	O
,	O
DONNA	O
A.	O
JAMES	O
,	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
,	O
EDWARD	O
J.	O
LUDWIG	O
,	O
STEPHEN	O
P.	O
MACMILLAN	O
,	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
,	O
DAVID	O
ROUX	O
,	O
JOHN	O
E.	O
SUNUNU	O
,	O
ELLEN	O
M.	O
ZANE	O
,	O
,	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
,	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
,	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions.	O
,	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011.	O
,	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business.	O
,	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University.	O
,	O
,	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
,	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders.	O
,	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents.	O
,	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota.	O
,	O
,	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
,	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
,	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa.	O
,	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific.	O
,	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India.	O
,	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
,	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
,	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
,	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
,	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
,	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
,	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
,	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
,	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
J.	O
Brennan	O
,	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
,	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development.	O
,	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes.	O
,	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division.	O
,	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation.	O
,	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College.	O
,	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
,	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
,	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
,	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
,	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
,	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
,	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
,	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
Arthur	O
Butcher	O
,	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
,	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions.	O
,	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions.	O
,	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University.	O
,	O
,	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
,	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations.	O
,	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people.	O
,	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris.	O
,	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer.	O
,	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank.	O
,	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
,	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
,	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
,	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
,	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
,	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
,	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
,	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
,	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
,	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies.	O
,	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group.	O
,	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics.	O
,	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London.	O
,	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
,	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
,	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
,	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
,	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
,	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
,	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
,	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joseph	O
M.	O
Fitzgerald	O
,	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
,	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee.	O
,	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business.	O
,	O
,	O
,	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
,	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
,	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
,	O
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing.	O
,	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes.	O
,	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007.	O
,	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts.	O
,	O
Jeff	O
Mirviss	O
,	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer.	O
,	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific.	O
,	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies.	O
,	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
,	O
,	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
,	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
,	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain.	O
,	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency.	O
,	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan.	O
,	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago.	O
,	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community.	O
,	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
,	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
,	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
,	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
,	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
,	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
,	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
,	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
P.	O
Phalen	O
,	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
,	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America.	O
,	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy.	O
,	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division.	O
,	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University.	O
,	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
,	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
,	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
,	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
,	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
,	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
,	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
,	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
David	O
A.	O
Pierce	O
,	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
,	O
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases.	O
,	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility.	O
,	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army.	O
,	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University.	O
,	O
,	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Timothy	O
A.	O
Pratt	O
,	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
,	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security.	O
,	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee.	O
,	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
,	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
,	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
,	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
,	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
,	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
,	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States.	O
,	O
See	O
More	O
,	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
,	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products.	O
,	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge.	O
,	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota.	O
,	O
,	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
,	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
,	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe.	O
,	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer.	O
,	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
,	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University.	O
,	O
,	O
Nelda	O
J.	O
Connors	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton.	O
,	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Charles	O
J.	O
Dockendorff	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College.	O
,	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Yoshiaki	O
Fujimori	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees.	O
,	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Donna	O
A.	O
James	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University.	O
,	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University.	O
,	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Edward	O
J.	O
Ludwig	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University.	O
,	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Stephen	O
P.	O
MacMillan	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program.	O
,	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
Michael	O
F.	O
Mahoney	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University.	O
,	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University.	O
,	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
David	O
J.	O
Roux	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College.	O
,	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
.	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology	O
.	O
Top	O
,	O
John	O
E.	O
Sununu	O
About	O
Leadership	O
Leadership	O
A	O
A	O
Resize	O
Print	O
Working	O
in	O
healthcare	O
is	O
n't	O
just	O
a	O
job	O
.	O
It	O
's	O
a	O
calling	O
--	O
to	O
develop	O
solutions	O
that	O
transform	O
patients	O
'	O
lives	O
and	O
help	O
healthcare	O
professionals	O
provide	O
the	O
best	O
care	O
.	O
Meet	O
the	O
team	O
that	O
inspires	O
our	O
employees	O
to	O
fulfill	O
that	O
purpose	O
and	O
ensures	O
high	O
performance	O
for	O
our	O
shareholders	O
.	O
Anchor	O
component	O
is	O
added	O
but	O
not	O
authored	O
Executive	O
Committee	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
KEVIN	PERSON
BALLINGER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
SUPRATIM	PERSON
BOSE	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
DANIEL	PERSON
J.	PERSON
BRENNAN	PERSON
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
ART	PERSON
BUTCHER	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
WENDY	PERSON
CARRUTHERS	PERSON
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
KEITH	PERSON
D.	PERSON
DAWKINS	PERSON
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
JOSEPH	PERSON
M.	PERSON
FITZGERALD	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
EDWARD	PERSON
MACKEY	PERSON
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
JEFF	PERSON
MIRVISS	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
MAULIK	PERSON
NANAVATY	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
MICHAEL	PERSON
P.	PERSON
PHALEN	PERSON
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
DAVID	PERSON
A.	PERSON
PIERCE	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
TIMOTHY	PERSON
A.	PERSON
PRATT	PERSON
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
BRAD	PERSON
SORENSON	PERSON
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
ERIC	PERSON
THÉPAUT	PERSON
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Board	O
of	O
Directors	O
NELDA	O
J.	O
CONNORS	O
CHARLES	O
J.	O
DOCKENDORFF	O
YOSHIAKI	O
FUJIMORI	O
DONNA	O
A.	O
JAMES	O
KRISTINA	O
M.	O
JOHNSON	O
,	O
Ph.D.	O
.	O
EDWARD	O
J.	O
LUDWIG	O
STEPHEN	O
P.	O
MACMILLAN	O
MICHAEL	PERSON
F.	PERSON
MAHONEY	PERSON
DAVID	O
ROUX	O
JOHN	O
E.	O
SUNUNU	O
ELLEN	O
M.	O
ZANE	O
Michael	O
F.	O
Mahoney	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
Kevin	O
Ballinger	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
Kevin	O
Ballinger	O
is	O
Senior	O
Vice	O
President	O
and	O
Global	O
President	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
that	O
diagnose	O
and	O
treat	O
coronary	O
artery	O
disease	O
and	O
cardiac	O
valve	O
disorders	O
.	O
Ballinger	O
has	O
more	O
than	O
17	O
years	O
of	O
interventional	O
cardiology	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
engineering	O
and	O
general	O
management	O
positions	O
within	O
Boston	O
Scientific	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
unit	O
,	O
including	O
overseeing	O
the	O
development	O
of	O
the	O
company	O
's	O
first	O
drug-eluting	O
stents	O
.	O
Ballinger	O
earned	O
a	O
B.S.	O
in	O
Mechanical	O
Engineering	O
from	O
Michigan	O
Tech	O
University	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Supratim	O
Bose	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
Supratim	O
Bose	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Asia-Pac	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
AMEA	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
Supratim	O
oversees	O
the	O
Company	O
's	O
business	O
and	O
growth	O
opportunities	O
across	O
Asia-Pacific	O
,	O
the	O
world	O
's	O
fastest	O
growing	O
region	O
,	O
plus	O
the	O
Middle	O
East	O
and	O
Africa	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
in	O
January	O
2012	O
,	O
Supratim	O
was	O
Founder	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Singapore-based	O
Bose	O
Consulting	O
Group	O
,	O
which	O
specialized	O
in	O
strategic	O
management	O
consulting	O
services	O
for	O
the	O
healthcare	O
industry	O
.	O
Previously	O
,	O
he	O
worked	O
for	O
nearly	O
30	O
years	O
at	O
Johnson	O
&	O
Johnson	O
,	O
where	O
he	O
concluded	O
his	O
tenure	O
as	O
Company	O
Group	O
Chairman	O
of	O
its	O
Medical	O
Devices	O
and	O
Diagnostics	O
-LRB-	O
MD&D	O
-RRB-	O
business	O
.	O
In	O
this	O
role	O
,	O
he	O
managed	O
Johnson	O
&	O
Johnson	O
's	O
MD&D	O
companies	O
throughout	O
Asia-Pacific	O
,	O
including	O
Japan	O
,	O
having	O
pioneered	O
its	O
entry	O
in	O
all	O
emerging	O
markets	O
in	O
Asia	O
,	O
including	O
China	O
,	O
India	O
,	O
and	O
Vietnam	O
.	O
During	O
his	O
tenure	O
,	O
he	O
also	O
created	O
the	O
company	O
's	O
research	O
and	O
development	O
capability	O
in	O
the	O
region	O
and	O
led	O
the	O
development	O
and	O
growth	O
of	O
local	O
talent	O
.	O
Under	O
Supratim	O
's	O
leadership	O
,	O
the	O
organization	O
partnered	O
closely	O
with	O
key	O
external	O
stakeholders	O
to	O
shape	O
the	O
healthcare	O
environment	O
,	O
and	O
was	O
recognized	O
by	O
external	O
agencies	O
as	O
one	O
of	O
the	O
top	O
companies	O
to	O
work	O
for	O
in	O
Asia-Pacific	O
.	O
Supratim	O
joined	O
Johnson	O
&	O
Johnson	O
Ltd.	O
.	O
India	O
in	O
1981	O
,	O
and	O
held	O
a	O
variety	O
of	O
management	O
positions	O
of	O
increasing	O
responsibility	O
leading	O
up	O
to	O
his	O
appointment	O
as	O
Company	O
Group	O
Chairman	O
of	O
MD&D	O
.	O
He	O
has	O
extensive	O
and	O
proven	O
experience	O
in	O
building	O
markets	O
in	O
this	O
region	O
.	O
Prior	O
to	O
J&J	O
,	O
he	O
served	O
at	O
one	O
of	O
the	O
top	O
growing	O
pharmaceutical	O
start-ups	O
in	O
India	O
.	O
Supratim	O
earned	O
a	O
B.S.	O
in	O
Chemistry/Physics	O
,	O
a	O
M.S.	O
in	O
Biophysics	O
and	O
a	O
Master	O
in	O
Management	O
Studies	O
from	O
the	O
Jamnalal	O
Bajaj	O
Institute	O
of	O
Management	O
Studies	O
at	O
the	O
University	O
of	O
Bombay	O
.	O
He	O
served	O
as	O
a	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
at	O
Quattro	O
Vascular	O
Pte	O
Ltd	O
and	O
TriReme	O
Medical	O
,	O
and	O
member	O
of	O
the	O
Advisory	O
Board	O
at	O
Singapore	O
Management	O
University	O
's	O
Lee	O
Kong	O
Chian	O
School	O
of	O
Business	O
.	O
He	O
continues	O
to	O
teach	O
at	O
the	O
Nanyang	O
Business	O
School	O
,	O
Singapore	O
,	O
as	O
a	O
visiting	O
faculty	O
member	O
.	O
See	O
More	O
Daniel	O
J.	O
Brennan	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
Daniel	O
Brennan	O
is	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
several	O
Company	O
functions	O
,	O
including	O
Global	O
Controllership	O
,	O
Corporate	O
Finance	O
,	O
Treasury	O
,	O
Corporate	O
Tax	O
,	O
Corporate	O
Analysis	O
and	O
Control	O
,	O
and	O
Corporate	O
New	O
Business	O
Development	O
.	O
Previously	O
,	O
he	O
served	O
as	O
Senior	O
Vice	O
President	O
and	O
Corporate	O
Controller	O
.	O
In	O
this	O
role	O
,	O
Brennan	O
was	O
responsible	O
for	O
the	O
Global	O
Controllership	O
organization	O
,	O
including	O
the	O
Company	O
's	O
accounting	O
and	O
financial	O
planning	O
processes	O
.	O
Brennan	O
joined	O
Boston	O
Scientific	O
in	O
1996	O
and	O
has	O
served	O
in	O
a	O
number	O
of	O
financial	O
roles	O
of	O
increasing	O
responsibility	O
,	O
including	O
Assistant	O
Corporate	O
Controller	O
;	O
Vice	O
President-Worldwide	O
Financial	O
&	O
Strategic	O
Planning	O
;	O
Vice	O
President-Investor	O
Relations	O
,	O
Vice	O
President-International	O
Finance	O
and	O
Vice	O
President-Finance	O
&	O
Information	O
Technology	O
for	O
the	O
company	O
's	O
Cardiovascular	O
Division	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Brennan	O
held	O
several	O
finance	O
positions	O
at	O
Millipore	O
Corporation	O
and	O
Standex	O
Corporation	O
.	O
Brennan	O
is	O
a	O
Certified	O
Public	O
Accountant	O
and	O
earned	O
his	O
B.S.	O
in	O
Finance	O
and	O
Investments	O
and	O
his	O
M.B.A.	O
from	O
Babson	O
College	O
.	O
See	O
More	O
Arthur	O
Butcher	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Arthur	O
Butcher	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
for	O
Boston	O
Scientific	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
less	O
invasive	O
devices	O
for	O
treating	O
gastrointestinal	O
and	O
pulmonary	O
conditions	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Butcher	O
was	O
Vice	O
President	O
&	O
General	O
Manager	O
,	O
Japan	O
Endoscopy	O
Business	O
.	O
Since	O
joining	O
the	O
Company	O
in	O
1997	O
,	O
he	O
has	O
held	O
a	O
variety	O
of	O
marketing	O
and	O
strategic	O
planning	O
management	O
positions	O
within	O
the	O
Endoscopy	O
and	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
divisions	O
.	O
Butcher	O
holds	O
a	O
B.A.	O
in	O
International	O
Relations	O
from	O
the	O
University	O
of	O
Pennsylvania	O
and	O
an	O
M.B.A.	O
from	O
Columbia	O
University	O
.	O
Wendy	O
Carruthers	O
Senior	O
Vice	O
President	O
,	O
Human	DEPARTMENT
Resources	DEPARTMENT
Wendy	O
Carruthers	O
is	O
Senior	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
Boston	O
Scientific	O
Corporation	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
she	O
provides	O
strategic	O
leadership	O
to	O
the	O
global	O
HR	O
function	O
,	O
including	O
HR	O
operations	O
,	O
total	O
rewards	O
,	O
talent	O
management	O
,	O
diversity	O
and	O
inclusion	O
,	O
and	O
community	O
relations	O
.	O
Prior	O
to	O
her	O
current	O
role	O
,	O
Carruthers	O
served	O
as	O
Vice	O
President	O
of	O
Global	O
Talent	O
Management	O
for	O
Boston	O
Scientific	O
,	O
responsible	O
for	O
all	O
aspects	O
of	O
global	O
talent	O
management	O
including	O
the	O
design	O
,	O
development	O
and	O
implementation	O
of	O
global	O
processes	O
and	O
systems	O
to	O
enable	O
managers	O
to	O
identify	O
,	O
attract	O
and	O
develop	O
people	O
.	O
Carruthers	O
has	O
been	O
with	O
Boston	O
Scientific	O
since	O
2004	O
and	O
was	O
previously	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
for	O
the	O
company	O
's	O
Europe	O
,	O
Middle	O
East	O
and	O
Africa	O
-LRB-	O
EMEA	O
-RRB-	O
region	O
,	O
based	O
in	O
Paris	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Carruthers	O
was	O
Vice	O
President	O
of	O
Human	DEPARTMENT
Resources	DEPARTMENT
,	O
Europe	O
for	O
global	O
telecommunications	O
company	O
Cable	O
&	O
Wireless	O
.	O
She	O
also	O
previously	O
worked	O
in	O
human	O
resources	O
for	O
Diageo	O
,	O
a	O
premium	O
drinks	O
business	O
,	O
and	O
Tesco	O
,	O
a	O
U.K.	O
retailer	O
.	O
A	O
native	O
of	O
Great	O
Britain	O
,	O
Carruthers	O
has	O
lived	O
and	O
worked	O
in	O
the	O
U.K.	O
,	O
France	O
,	O
Italy	O
,	O
Australia	O
and	O
the	O
United	O
States	O
.	O
She	O
holds	O
a	O
B.A.	O
First	O
Class	O
Honors	O
Degree	O
in	O
Modern	O
Languages	O
and	O
is	O
a	O
Fellow	O
of	O
the	O
Chartered	O
Institute	O
of	O
Personnel	O
and	O
Development	O
.	O
She	O
is	O
also	O
on	O
the	O
Board	O
of	O
the	O
Boston	O
Scientific	O
Foundation	O
and	O
a	O
member	O
of	O
the	O
Board	O
of	O
Advisors	O
of	O
the	O
Greater	O
Boston	O
Food	O
Bank	O
.	O
See	O
More	O
Keith	O
D.	O
Dawkins	O
,	O
M.D.	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
Keith	O
Dawkins	O
,	O
M.D.	O
,	O
is	O
Executive	O
Vice	O
President	O
and	O
Global	O
Chief	O
Medical	O
Officer	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
enhancing	O
the	O
Company	O
's	O
global	O
Clinical	O
programs	O
and	O
strategies	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
which	O
he	O
assumed	O
in	O
January	O
2012	O
,	O
Dr.	O
Dawkins	O
was	O
Chief	O
Medical	O
Officer	O
of	O
Boston	O
Scientific	O
's	O
Cardiology	O
,	O
Rhythm	O
and	O
Vascular	O
Group	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2008	O
as	O
Senior	O
Vice	O
President	O
and	O
Associate	O
Chief	O
Medical	O
Officer	O
for	O
the	O
Company	O
's	O
Cardiovascular	O
-LRB-	O
CV	O
-RRB-	O
business	O
.	O
While	O
in	O
this	O
role	O
,	O
he	O
led	O
Boston	O
Scientific	O
's	O
Clinical	O
Integration	O
Project	O
,	O
which	O
brought	O
together	O
its	O
former	O
CV	O
and	O
Cardiac	O
Rhythm	O
Management	O
Clinical	O
organizations	O
under	O
the	O
Company	O
's	O
CRV	O
Group	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Dr.	O
Dawkins	O
was	O
a	O
practicing	O
interventional	O
cardiologist	O
for	O
more	O
than	O
20	O
years	O
in	O
England	O
.	O
He	O
has	O
earned	O
a	O
series	O
of	O
clinical	O
,	O
research	O
and	O
academic	O
distinctions	O
,	O
including	O
a	O
Post-Doctoral	O
Research	O
Fellowship	O
at	O
Stanford	O
University	O
as	O
a	O
Fulbright	O
Scholar	O
.	O
Dr.	O
Dawkins	O
served	O
as	O
President	O
of	O
the	O
British	O
Cardiovascular	O
Intervention	O
Society	O
,	O
and	O
held	O
numerous	O
appointments	O
on	O
hospital	O
,	O
regional	O
and	O
national	O
committees	O
,	O
including	O
the	O
National	O
Institute	O
for	O
Health	O
and	O
Clinical	O
Excellence	O
-LRB-	O
NICE	O
-RRB-	O
.	O
He	O
has	O
been	O
an	O
author	O
on	O
more	O
than	O
450	O
academic	O
publications	O
and	O
presentations	O
on	O
a	O
variety	O
of	O
cardiac	O
topics	O
.	O
Dr.	O
Dawkins	O
earned	O
a	O
First-Class	O
Honours	O
degree	O
in	O
Pathology	O
at	O
London	O
University	O
and	O
Guy	O
's	O
Hospital	O
.	O
He	O
trained	O
in	O
cardiology	O
at	O
Oxford	O
and	O
at	O
the	O
Brompton	O
&	O
St.	O
George	O
's	O
Hospital	O
in	O
London	O
.	O
See	O
More	O
Joseph	O
M.	O
Fitzgerald	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
Joe	O
Fitzgerald	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Rhythm	O
Management	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Fitzgerald	O
was	O
President	O
of	O
Boston	O
Scientific	O
's	O
Endovascular	O
Unit	O
,	O
which	O
included	O
the	O
Company	O
's	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
,	O
Electrophysiology	O
,	O
Neurovascular	O
and	O
IVUS	O
businesses	O
.	O
Previously	O
,	O
he	O
held	O
a	O
number	O
of	O
senior	O
leadership	O
positions	O
at	O
Boston	O
Scientific	O
,	O
including	O
President	O
of	O
our	O
Electrophysiology	O
business	O
and	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
U.S.	O
Sales	O
for	O
the	O
Company	O
's	O
Neurovascular	O
business	O
.	O
Edward	O
Mackey	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
Edward	O
Mackey	O
is	O
Executive	O
Vice	O
President	O
,	O
Operations	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
Global	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
,	O
Quality	O
and	O
Regulatory	O
,	O
Information	O
Services	O
,	O
Global	O
Business	O
Services	O
,	O
Global	O
Business	O
Excellence	O
,	O
Corporate	O
Research	O
and	O
Development	O
and	O
Corporate	O
Strategy	O
and	O
Marketing	O
.	O
Ed	O
is	O
a	O
seasoned	O
executive	O
with	O
a	O
track	O
record	O
of	O
delivering	O
strong	O
results	O
,	O
leading	O
large	O
teams	O
and	O
developing	O
innovative	O
strategies	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2015	O
,	O
Ed	O
was	O
Worldwide	O
President	O
of	O
DePuy	O
Synthes	O
Power	O
Tools	O
,	O
a	O
division	O
of	O
Johnson	O
&	O
Johnson	O
,	O
after	O
having	O
served	O
as	O
Vice	O
President	O
of	O
Integration	O
for	O
Johnson	O
&	O
Johnson	O
's	O
acquisition	O
of	O
Synthes	O
.	O
Early	O
in	O
his	O
career	O
,	O
Ed	O
held	O
management	O
positions	O
in	O
Operations	DEPARTMENT
,	O
Quality	O
and	O
Product	O
Development	O
at	O
Raytheon	O
's	O
Missile	O
Systems	O
division	O
.	O
In	O
1995	O
,	O
he	O
moved	O
to	O
Johnson	O
&	O
Johnson	O
Orthopaedics	O
as	O
a	O
plant	O
manager	O
and	O
progressed	O
through	O
a	O
series	O
of	O
manufacturing	O
and	O
supply	O
chain	O
leadership	O
roles	O
,	O
becoming	O
Worldwide	O
Vice	O
President	O
of	O
Supply	O
Chain	O
and	O
Manufacturing	O
for	O
DePuy	O
in	O
2007	O
.	O
Mr.	O
Mackey	O
holds	O
a	O
Bachelor	O
of	O
Science	O
degree	O
in	O
Mechanical	O
Engineering	O
from	O
Worcester	O
Polytechnic	O
Institute	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Massachusetts	O
.	O
Jeff	O
Mirviss	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
Jeff	O
Mirviss	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
that	O
capacity	O
he	O
is	O
responsible	O
for	O
developing	O
and	O
bringing	O
to	O
market	O
innovative	O
solutions	O
for	O
treating	O
patients	O
with	O
high	O
blood	O
pressure	O
,	O
vascular	O
system	O
blockages	O
and	O
cancer	O
.	O
Mirviss	O
has	O
more	O
than	O
23	O
years	O
of	O
experience	O
in	O
medical	O
device	O
and	O
pharmaceutical	O
general	O
management	O
,	O
marketing	O
and	O
sales	O
.	O
He	O
has	O
held	O
positions	O
of	O
increasing	O
responsibility	O
since	O
1997	O
at	O
Boston	O
Scientific	O
.	O
In	O
addition	O
to	O
his	O
roles	O
at	O
Boston	O
Scientific	O
,	O
Mirviss	O
has	O
worked	O
for	O
companies	O
ranging	O
in	O
size	O
from	O
a	O
pre-revenue	O
venture-backed	O
medical	O
device	O
startup	O
to	O
Dow	O
30	O
companies	O
.	O
A	O
resident	O
of	O
Plymouth	O
,	O
Minnesota	O
,	O
Mirviss	O
holds	O
a	O
Bachelor	O
's	O
degree	O
from	O
the	O
University	O
of	O
Minnesota	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
St.	O
Thomas	O
.	O
Maulik	O
Nanavaty	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Maulik	O
Nanavaty	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Neuromodulation	O
Division	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
innovation	O
leader	O
in	O
less-invasive	O
microelectronic	O
implantable	O
technologies	O
used	O
to	O
treat	O
chronic	O
neuropathic	O
pain	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Nanavaty	O
was	O
President	O
,	O
Representative	O
Director	O
of	O
Boston	O
Scientific	O
Japan	O
.	O
Previously	O
,	O
he	O
was	O
Vice	O
President	O
and	O
General	O
Manager	O
of	O
the	O
Company	O
's	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
business	O
in	O
Japan	O
.	O
During	O
his	O
tenure	O
,	O
Nanavaty	O
managed	O
the	O
successful	O
expansion	O
of	O
Cardiology	O
business	O
in	O
that	O
country	O
.	O
He	O
joined	O
Boston	O
Scientific	O
in	O
2005	O
as	O
Vice	O
President	O
for	O
Corporate	O
Strategy	O
for	O
Japan	O
,	O
where	O
he	O
led	O
business	O
transformation	O
and	O
increased	O
operational	O
efficiency	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
,	O
Nanavaty	O
spent	O
16	O
years	O
working	O
in	O
various	O
executive	O
positions	O
at	O
Baxter	O
International	O
,	O
Inc.	O
,	O
and	O
Baxter	O
Japan	O
.	O
Nanavaty	O
earned	O
a	O
Ph.D.	O
in	O
Pharmaceutical	O
Sciences	O
from	O
the	O
University	O
of	O
Illinois	O
and	O
a	O
M.B.A.	O
from	O
the	O
University	O
of	O
Chicago	O
.	O
Nanavaty	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
California	O
Health	O
Institute	O
-LRB-	O
CHI	O
-RRB-	O
.	O
CHI	O
is	O
an	O
independent	O
501	O
-LRB-	O
c	O
-RRB-	O
-LRB-	O
6	O
-RRB-	O
organization	O
devoted	O
to	O
researching	O
and	O
advocating	O
policy	O
to	O
forward	O
the	O
interests	O
of	O
California	O
's	O
biomedical	O
community	O
.	O
See	O
More	O
Michael	O
P.	O
Phalen	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
MedSurg	O
Michael	O
Phalen	O
is	O
Executive	O
Vice	O
President	O
and	O
President	O
,	O
Medical	O
Surgery	O
-LRB-	O
MedSurg	O
-RRB-	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
plans	O
and	O
executes	O
Boston	O
Scientific	O
's	O
growth	O
strategies	O
for	O
the	O
Company	O
's	O
Endoscopy	O
,	O
Urology/Women	O
's	O
Health	O
and	O
Neuromodulation	O
businesses	O
.	O
Phalen	O
also	O
oversees	O
Boston	O
Scientific	O
operations	O
in	O
Canada	O
and	O
Latin	O
America	O
.	O
Prior	O
to	O
assuming	O
his	O
current	O
position	O
in	O
January	O
2012	O
,	O
Phalen	O
was	O
President	O
of	O
Boston	O
Scientific	O
International	O
.	O
He	O
was	O
responsible	O
for	O
planning	O
and	O
executing	O
Boston	O
Scientific	O
's	O
international	O
growth	O
strategy	O
.	O
Phalen	O
joined	O
Boston	O
Scientific	O
in	O
1988	O
and	O
held	O
various	O
management	O
positions	O
of	O
increasing	O
responsibilities	O
including	O
Territory	O
Manager	O
,	O
Product	O
Manager	O
,	O
Regional	O
Sales	O
Manager	O
,	O
Group	O
Product	O
Manager	O
,	O
Director	O
of	O
Marketing	O
,	O
Vice	O
President	O
of	O
Global	O
Marketing	O
and	O
Senior	O
Vice	O
President	O
and	O
President	O
of	O
the	O
company	O
's	O
Endoscopy	O
division	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Phalen	O
held	O
management	O
positions	O
with	O
MD	O
Technology	O
,	O
Kendall	O
Healthcare	O
and	O
Pennwalt	O
Pharmaceuticals	O
.	O
He	O
earned	O
a	O
B.S.	O
in	O
General	O
Science	O
from	O
Villanova	O
University	O
and	O
an	O
M.B.A.	O
from	O
Fairleigh	O
Dickinson	O
University	O
.	O
See	O
More	O
David	O
A.	O
Pierce	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
Dave	O
Pierce	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Urology	DEPARTMENT
and	DEPARTMENT
Pelvic	DEPARTMENT
Health	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
develops	O
and	O
executes	O
strategies	O
to	O
bring	O
to	O
market	O
industry-leading	O
solutions	O
for	O
treating	O
patients	O
with	O
urological	O
,	O
urogynecological	O
,	O
and	O
gynecological	O
diseases	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Pierce	O
was	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Endoscopy	O
Division	O
,	O
leading	O
the	O
Endoscopy	O
business	O
with	O
a	O
focus	O
on	O
strategic	O
portfolio	O
expansion	O
and	O
global	O
commercial	O
execution	O
.	O
He	O
joined	O
the	O
Company	O
in	O
1991	O
as	O
a	O
Territory	O
Manager	O
before	O
assuming	O
various	O
management-level	O
positions	O
of	O
increasing	O
responsibility	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
Pierce	O
worked	O
as	O
a	O
Senior	O
Sales	O
Representative	O
for	O
Airborne	O
Express	O
and	O
served	O
as	O
a	O
Captain	O
in	O
the	O
United	O
States	O
Army	O
.	O
Pierce	O
earned	O
a	O
B.S.	O
in	O
Business	O
Administration	O
from	O
Norwich	O
University	O
and	O
an	O
M.B.A.	O
from	O
Boston	O
University	O
.	O
Timothy	O
A.	O
Pratt	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
Tim	O
Pratt	O
is	O
Executive	O
Vice	O
President	O
,	O
Chief	O
Administrative	O
Officer	O
,	O
General	O
Counsel	O
and	O
Secretary	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
worldwide	O
management	O
of	O
Boston	O
Scientific	O
's	O
Legal	O
functions	O
,	O
Global	O
Compliance	O
,	O
Government	O
Affairs	O
,	O
Aviation	O
,	O
and	O
Global	O
Security	O
.	O
Mr.	O
Pratt	O
served	O
as	O
President	O
and	O
Chairman	O
of	O
the	O
Federation	O
of	O
Defense	O
&	O
Corporate	O
Counsel	O
-LRB-	O
FDCC	O
-RRB-	O
.	O
He	O
also	O
serves	O
as	O
a	O
Director	O
on	O
the	O
Boards	O
of	O
Lawyers	O
for	O
Civil	O
Justice	O
-LRB-	O
LCJ	O
-RRB-	O
,	O
DRI	O
-	O
The	O
Voice	O
of	O
the	O
Defense	O
Bar	O
,	O
and	O
the	O
New	O
England	O
Legal	O
Foundation	O
-LRB-	O
NELF	O
-RRB-	O
.	O
Mr.	O
Pratt	O
is	O
a	O
past	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
for	O
the	O
Advanced	O
Medical	O
Technology	O
Association	O
-LRB-	O
AdvaMed	O
-RRB-	O
and	O
also	O
served	O
on	O
their	O
Executive	O
Committee	O
.	O
Mr.	O
Pratt	O
earned	O
his	O
Bachelor	O
of	O
Arts	O
degree	O
at	O
Tarkio	O
College	O
and	O
graduated	O
Order	O
of	O
the	O
Coif	O
from	O
Drake	O
University	O
Law	O
School	O
,	O
where	O
he	O
served	O
as	O
editor-in-chief	O
of	O
the	O
Drake	O
Law	O
Review	O
.	O
Prior	O
to	O
joining	O
Boston	O
Scientific	O
in	O
2008	O
,	O
Mr.	O
Pratt	O
was	O
a	O
partner	O
and	O
trial	O
attorney	O
with	O
the	O
law	O
firm	O
of	O
Shook	O
,	O
Hardy	O
&	O
Bacon	O
.	O
While	O
there	O
,	O
he	O
was	O
named	O
a	O
Leading	O
National	O
Products	O
Liability	O
Lawyer	O
by	O
Chambers	O
USA	O
,	O
one	O
of	O
the	O
Top	O
,	O
500	O
Litigators	O
in	O
America	O
by	O
Lawdragon	O
,	O
and	O
one	O
of	O
the	O
Best	O
Lawyers	O
in	O
America	O
.	O
In	O
October	O
of	O
2013	O
,	O
he	O
was	O
recognized	O
by	O
The	O
Legal	O
500	O
and	O
named	O
to	O
the	O
``	O
Corporate	O
Counsel	O
100	O
''	O
list	O
,	O
which	O
identifies	O
the	O
top	O
most	O
powerful	O
corporate	O
legal	O
advisers	O
in	O
the	O
United	O
States	O
.	O
See	O
More	O
Brad	O
Sorenson	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
Brad	O
Sorenson	O
is	O
Senior	O
Vice	O
President	O
,	O
Manufacturing	DEPARTMENT
and	DEPARTMENT
Supply	DEPARTMENT
Chain	DEPARTMENT
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
In	O
this	O
role	O
,	O
he	O
is	O
responsible	O
for	O
the	O
global	O
manufacturing	O
and	O
distribution	O
of	O
Boston	O
Scientific	O
's	O
products	O
.	O
Sorenson	O
has	O
more	O
than	O
16	O
years	O
of	O
medical	O
device	O
manufacturing	O
experience	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
he	O
held	O
a	O
variety	O
of	O
Operations	DEPARTMENT
positions	O
at	O
Boston	O
Scientific	O
,	O
supporting	O
the	O
Cardiac	O
Rhythm	O
Management	O
,	O
Neuromodulation	O
,	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
,	O
Peripheral	DEPARTMENT
Interventions	DEPARTMENT
and	O
Structural	O
Heart	O
businesses	O
.	O
Before	O
joining	O
Boston	O
Scientific	O
,	O
he	O
was	O
President	O
and	O
COO	O
of	O
QRS	O
Diagnostic	O
and	O
held	O
manufacturing	O
management	O
positions	O
at	O
Federal	O
Cartridge	O
.	O
Sorenson	O
earned	O
a	O
B.A.	O
in	O
Economics	O
from	O
Gustavus	O
Adolphus	O
College	O
in	O
St.	O
Peter	O
,	O
MN	O
and	O
an	O
MBA	O
from	O
the	O
University	O
of	O
Minnesota	O
.	O
Eric	O
Thépaut	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
Eric	O
Thépaut	O
is	O
Senior	O
Vice	O
President	O
and	O
President	O
,	O
Europe	O
for	O
Boston	O
Scientific	O
and	O
a	O
member	O
of	O
its	O
Executive	O
Committee	O
.	O
Based	O
at	O
the	O
regional	O
headquarters	O
in	O
Paris	O
,	O
he	O
is	O
responsible	O
for	O
Boston	O
Scientific	O
's	O
businesses	O
in	O
Europe	O
.	O
Prior	O
to	O
his	O
current	O
role	O
,	O
Thépaut	O
was	O
Vice	O
President	O
Interventional	DEPARTMENT
Cardiology	DEPARTMENT
&	O
Structural	O
Heart	O
,	O
Europe	O
,	O
since	O
2012	O
.	O
He	O
joined	O
Boston	O
Scientific	O
Europe	O
,	O
in	O
1996	O
,	O
as	O
a	O
business	O
finance	O
manager	O
and	O
earned	O
roles	O
of	O
increasing	O
responsibility	O
in	O
Marketing	O
and	O
Finance	O
,	O
becoming	O
Vice	O
President	O
,	O
Finance	O
,	O
Europe	O
,	O
in	O
2002	O
.	O
Eric	O
was	O
next	O
promoted	O
to	O
General	O
Manager	O
and	O
Vice	O
President	O
,	O
France	O
,	O
and	O
then	O
the	O
France	O
Group	O
,	O
comprised	O
of	O
France	O
,	O
Benelux	O
and	O
Middle	O
East	O
North	O
Africa	O
.	O
Before	O
coming	O
to	O
Boston	O
Scientific	O
,	O
Eric	O
held	O
management	O
positions	O
in	O
treasury	O
operations	O
and	O
auditing	O
at	O
Nestlé	O
and	O
financial	O
planning	O
&	O
analysis	O
at	O
Apple	O
Computer	O
.	O
Thépaut	O
has	O
driven	O
innovation	O
in	O
high	O
technology	O
businesses	O
throughout	O
his	O
career	O
,	O
leading	O
organizational	O
transformation	O
initiatives	O
and	O
development	O
programs	O
as	O
well	O
as	O
creating	O
new	O
selling	O
models	O
.	O
Eric	O
earned	O
his	O
MBA	O
at	O
Paris	O
Dauphine	O
University	O
.	O
Nelda	O
J.	O
Connors	O
Nelda	O
J.	O
Connors	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
December	O
2009	O
.	O
Ms.	O
Connors	O
is	O
the	O
founder	O
,	O
Chairwoman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Pine	O
Grove	O
Holdings	O
,	O
LLC	O
,	O
which	O
invests	O
in	O
companies	O
that	O
offer	O
original	O
equipment	O
,	O
manufactured	O
and	O
remanufactured	O
products	O
,	O
and	O
aftermarket	O
services	O
.	O
She	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Atkore	O
International	O
Inc.	O
from	O
December	O
2010	O
until	O
June	O
2011	O
.	O
Atkore	O
,	O
formerly	O
the	O
Electrical	O
and	O
Metal	O
Products	O
division	O
of	O
Tyco	O
International	O
,	O
became	O
a	O
privately-held	O
company	O
in	O
December	O
2010	O
.	O
Ms.	O
Connors	O
served	O
as	O
President	O
of	O
this	O
Tyco	O
division	O
from	O
2008	O
through	O
2010	O
.	O
Prior	O
to	O
joining	O
Tyco	O
,	O
she	O
served	O
as	O
Vice	O
President	O
at	O
Eaton	O
Corporation	O
from	O
2002	O
to	O
2008	O
where	O
she	O
held	O
several	O
positions	O
in	O
operations	O
,	O
continuous	O
improvement	O
,	O
and	O
general	O
management	O
.	O
Prior	O
to	O
joining	O
Eaton	O
,	O
Ms.	O
Connors	O
was	O
employed	O
in	O
a	O
number	O
of	O
executive	O
and	O
management	O
capacities	O
in	O
the	O
automotive	O
industry	O
.	O
Her	O
work	O
over	O
twenty-five	O
years	O
has	O
involved	O
responsibilities	O
in	O
the	O
U.S.	O
,	O
Europe	O
,	O
and	O
Asia	O
.	O
Ms.	O
Connors	O
is	O
a	O
Class	O
B	O
director	O
of	O
the	O
Federal	O
Reserve	O
Bank	O
of	O
Chicago	O
,	O
a	O
director	O
of	O
Claror	O
,	O
Inc.	O
,	O
Vesuvius	O
plc	O
and	O
EchoGlobal	O
Logistics	O
,	O
Inc.	O
,	O
and	O
an	O
appointed	O
member	O
for	O
the	O
Takata	O
Independent	O
Quality	O
Assurance	O
Panel	O
.	O
She	O
previously	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Atkore	O
and	O
Blount	O
International	O
.	O
Ms.	O
Connors	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
mechanical	O
engineering	O
from	O
the	O
University	O
of	O
Dayton	O
.	O
Charles	O
J.	O
Dockendorff	O
Charles	O
J.	O
Dockendorff	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
was	O
Executive	O
Vice	O
President	O
and	O
Chief	O
Financial	O
Officer	O
of	O
Covidien	O
plc	O
,	O
a	O
publicly	O
traded	O
medical	O
device	O
and	O
supplies	O
company	O
,	O
a	O
position	O
he	O
held	O
at	O
Covidien	O
and	O
its	O
predecessor	O
,	O
Tyco	O
Healthcare	O
,	O
from	O
1995	O
to	O
2015	O
.	O
Mr.	O
Dockendorff	O
joined	O
the	O
Kendall	O
Healthcare	O
Products	O
Company	O
,	O
the	O
foundation	O
of	O
the	O
Tyco	O
Healthcare	O
business	O
,	O
in	O
1989	O
as	O
Controller	O
and	O
was	O
named	O
Vice	O
President	O
and	O
Controller	O
in	O
1994	O
.	O
He	O
was	O
appointed	O
CFO	O
of	O
Tyco	O
Healthcare	O
in	O
1995	O
.	O
Prior	O
to	O
joining	O
Kendall/Tyco	O
Healthcare	O
,	O
Mr.	O
Dockendorff	O
was	O
the	O
Chief	O
Financial	O
Officer	O
,	O
Vice	O
President	O
of	O
Finance	O
and	O
Treasurer	O
of	O
Epsco	O
Inc.	O
and	O
Infrared	O
Industries	O
,	O
Inc.	O
.	O
In	O
addition	O
,	O
Mr.	O
Dockendorff	O
worked	O
as	O
an	O
accountant	O
for	O
Arthur	O
Young	O
&	O
Company	O
-LRB-	O
now	O
Ernst	O
&	O
Young	O
-RRB-	O
and	O
the	O
General	O
Motors	O
Corporation	O
.	O
Mr.	O
Dockendorff	O
is	O
a	O
director	O
of	O
Haemonetics	O
Corporation	O
and	O
Keysight	O
Technologies	O
,	O
Inc.	O
.	O
Mr.	O
Dockendorff	O
holds	O
a	O
bachelor	O
's	O
degree	O
in	O
accounting	O
from	O
the	O
University	O
of	O
Massachusetts	O
at	O
Amherst	O
and	O
a	O
M.S.	O
in	O
finance	O
from	O
Bentley	O
College	O
.	O
Yoshiaki	O
Fujimori	O
Yoshiaki	O
Fujimori	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2016	O
.	O
He	O
is	O
currently	O
an	O
adviser	O
to	O
the	O
LIXIL	O
Group	O
Corporation	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2016	O
,	O
and	O
was	O
the	O
President	O
and	O
CEO	O
of	O
the	O
LIXIL	O
Group	O
Corporation	O
from	O
August	O
2011	O
to	O
June	O
2016	O
.	O
Prior	O
to	O
joining	O
LIXIL	O
,	O
he	O
was	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
GE	O
Japan	O
from	O
January	O
2008	O
to	O
June	O
2011	O
.	O
In	O
his	O
25	O
years	O
at	O
GE	O
,	O
beginning	O
in	O
October	O
1986	O
,	O
he	O
held	O
a	O
variety	O
of	O
positions	O
including	O
Senior	O
Vice	O
President	O
and	O
CEO	O
of	O
a	O
number	O
of	O
Asian	O
and	O
global	O
business	O
divisions	O
including	O
Medical	O
Systems	O
,	O
Plastics	O
,	O
and	O
Capital	O
.	O
During	O
his	O
time	O
at	O
GE	O
,	O
Mr.	O
Fujimori	O
also	O
served	O
as	O
a	O
member	O
of	O
the	O
Corporate	O
Executive	O
Council	O
from	O
2001	O
to	O
2010	O
.	O
Mr.	O
Fujimori	O
started	O
his	O
career	O
at	O
Japanese	O
trading	O
company	O
,	O
Nissho	O
Iwai	O
Corporation	O
-LRB-	O
now	O
Sojitz	O
-RRB-	O
,	O
where	O
he	O
worked	O
from	O
April	O
1975	O
to	O
September	O
1986	O
.	O
Mr.	O
Fujimori	O
currently	O
serves	O
as	O
an	O
External	O
Director	O
of	O
Tokyo	O
Electric	O
Power	O
Company	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2012	O
and	O
External	O
Director	O
for	O
Takeda	O
Pharmaceutical	O
Company	O
Limited	O
,	O
a	O
role	O
he	O
has	O
held	O
since	O
June	O
2016	O
.	O
Also	O
,	O
from	O
June	O
2014	O
to	O
June	O
2016	O
,	O
Mr.	O
Fujimori	O
served	O
as	O
Chairman	O
of	O
the	O
Japan	O
Construction	O
Material	O
&	O
Housing	O
Equipment	O
Industries	O
Federation	O
.	O
Mr.	O
Fujimori	O
received	O
a	O
bachelor	O
's	O
degree	O
in	O
petroleum	O
engineering	O
from	O
the	O
University	O
of	O
Tokyo	O
and	O
his	O
master	O
's	O
degree	O
from	O
Carnegie	O
Mellon	O
Graduate	O
School	O
of	O
Business	O
,	O
where	O
he	O
serves	O
as	O
a	O
lifetime	O
member	O
of	O
the	O
Board	O
of	O
Trustees	O
.	O
Donna	O
A.	O
James	O
Donna	O
A.	O
James	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
July	O
2015	O
.	O
She	O
is	O
the	O
founder	O
of	O
Lardon	O
&	O
Associates	O
LLC	O
,	O
a	O
business	O
development	O
and	O
executive	O
advisory	O
services	O
firm	O
,	O
where	O
she	O
has	O
served	O
as	O
president	O
and	O
managing	O
director	O
since	O
April	O
2006	O
.	O
Ms.	O
James	O
has	O
more	O
than	O
30	O
years	O
of	O
diverse	O
management	O
and	O
leadership	O
experience	O
,	O
including	O
her	O
experience	O
at	O
Nationwide	O
Insurance	O
and	O
Financial	O
Services	O
,	O
where	O
she	O
served	O
in	O
a	O
variety	O
of	O
roles	O
beginning	O
in	O
1981	O
.	O
In	O
her	O
time	O
at	O
Nationwide	O
,	O
she	O
served	O
in	O
several	O
leadership	O
roles	O
,	O
including	O
serving	O
as	O
president	O
of	O
Nationwide	O
Strategic	O
Investments	O
,	O
a	O
division	O
of	O
Nationwide	O
Insurance	O
Company	O
,	O
from	O
2003	O
to	O
2006	O
at	O
which	O
time	O
she	O
had	O
direct	O
responsibility	O
for	O
developing	O
and	O
executing	O
strategies	O
for	O
U.S.	O
and	O
global	O
financial	O
services	O
subsidiaries	O
and	O
affiliates	O
.	O
Ms.	O
James	O
also	O
is	O
the	O
founder	O
and	O
chair	O
of	O
The	O
Center	O
for	O
Healthy	O
Families	O
,	O
a	O
non-profit	O
in	O
Columbus	O
,	O
Ohio	O
,	O
and	O
the	O
former	O
president	O
and	O
appointed	O
chair	O
of	O
the	O
National	O
Women	O
's	O
Business	O
Council	O
.	O
Ms.	O
James	O
currently	O
serves	O
as	O
a	O
director	O
of	O
Time	O
Warner	O
Cable	O
Inc.	O
,	O
L	O
Brands	O
,	O
Inc.	O
,	O
and	O
Marathon	O
Petroleum	O
Inc.	O
,	O
as	O
well	O
as	O
FIS	O
Group	O
,	O
a	O
privately-held	O
asset	O
management	O
and	O
investment	O
advisory	O
firm	O
.	O
She	O
received	O
her	O
B.S.	O
in	O
Accounting	O
from	O
North	O
Carolina	O
A&T	O
State	O
University	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
.	O
Kristina	O
M.	O
Johnson	O
,	O
Ph.D.	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2011	O
.	O
She	O
previously	O
served	O
as	O
a	O
director	O
from	O
April	O
2006	O
to	O
May	O
2009	O
.	O
She	O
has	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Cube	O
Hydro	O
Partners	O
,	O
LLC	O
,	O
an	O
independent	O
power	O
producer	O
of	O
clean	O
energy	O
,	O
since	O
2014	O
,	O
and	O
of	O
Enduring	O
Hydro	O
,	O
LLC	O
,	O
an	O
energy	O
consulting	O
firm	O
,	O
since	O
2011	O
.	O
From	O
May	O
2009	O
to	O
October	O
2010	O
,	O
Dr.	O
Johnson	O
served	O
as	O
Under	O
Secretary	O
of	O
Energy	O
at	O
the	O
U.S.	O
Department	O
of	O
Energy	O
.	O
Prior	O
to	O
this	O
,	O
Dr.	O
Johnson	O
was	O
Provost	O
and	O
Senior	O
Vice	O
President	O
of	O
Academic	O
Affairs	O
at	O
The	O
Johns	O
Hopkins	O
University	O
from	O
2007	O
to	O
2009	O
and	O
Dean	O
of	O
the	O
Pratt	O
School	O
of	O
Engineering	O
at	O
Duke	O
University	O
from	O
1999	O
to	O
2007	O
.	O
Dr.	O
Johnson	O
has	O
served	O
as	O
a	O
director	O
of	O
AES	O
Corporation	O
since	O
2011	O
and	O
Cisco	O
Systems	O
,	O
Inc.	O
since	O
2012	O
.	O
Dr.	O
Johnson	O
was	O
a	O
Fulbright	O
Faculty	O
Scholar	O
in	O
the	O
Department	O
of	O
Electrical	O
Engineering	O
at	O
the	O
University	O
of	O
Edinburgh	O
,	O
Scotland	O
,	O
a	O
NATO	O
Post-Doctoral	O
Fellow	O
at	O
Trinity	O
College	O
,	O
Dublin	O
,	O
Ireland	O
,	O
and	O
a	O
Professor	O
of	O
Electrical	O
and	O
Computer	O
Engineering	O
at	O
the	O
University	O
of	O
Colorado	O
at	O
Boulder	O
.	O
In	O
2015	O
,	O
Dr.	O
Johnson	O
was	O
inducted	O
into	O
the	O
National	O
Inventor	O
's	O
Hall	O
of	O
Fame	O
and	O
holds	O
119	O
U.S.	O
and	O
international	O
patents	O
in	O
liquid	O
crystal	O
displays	O
and	O
optoelectronics	O
.	O
Dr.	O
Johnson	O
received	O
B.S.	O
,	O
M.S.	O
and	O
Ph.D.	O
degrees	O
in	O
electrical	O
engineering	O
from	O
Stanford	O
University	O
.	O
Edward	O
J.	O
Ludwig	O
Edward	O
J.	O
Ludwig	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
March	O
2014	O
.	O
Mr.	O
Ludwig	O
is	O
the	O
former	O
Chairman	O
of	O
the	O
Board	O
of	O
Becton	O
,	O
Dickinson	O
and	O
Company	O
-LRB-	O
``	O
BDX	O
''	O
-RRB-	O
,	O
a	O
global	O
medical	O
technology	O
company	O
,	O
having	O
served	O
in	O
that	O
position	O
from	O
February	O
2002	O
through	O
June	O
2012	O
.	O
He	O
also	O
served	O
as	O
BDX	O
's	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2000	O
to	O
September	O
2011	O
and	O
as	O
its	O
President	O
from	O
May	O
1999	O
to	O
December	O
2008	O
.	O
Mr.	O
Ludwig	O
joined	O
BDX	O
as	O
a	O
Senior	O
Financial	O
Analyst	O
in	O
1979	O
.	O
Prior	O
to	O
joining	O
BDX	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
a	O
senior	O
auditor	O
with	O
Coopers	O
and	O
Lybrand	O
-LRB-	O
now	O
PricewaterhouseCoopers	O
-RRB-	O
where	O
he	O
earned	O
his	O
CPA	O
and	O
as	O
a	O
financial	O
and	O
strategic	O
analyst	O
at	O
Kidde	O
,	O
Inc.	O
.	O
Mr.	O
Ludwig	O
serves	O
as	O
Lead	O
Director	O
on	O
Aetna	O
Inc.	O
's	O
Board	O
of	O
Directors	O
and	O
chairs	O
its	O
Finance	O
Committee	O
and	O
is	O
a	O
member	O
of	O
the	O
Board	O
of	O
Directors	O
of	O
Xylem	O
,	O
Inc.	O
.	O
Additionally	O
,	O
Mr.	O
Ludwig	O
served	O
as	O
Vice	O
Chair	O
of	O
the	O
Board	O
of	O
Trustees	O
of	O
the	O
Hackensack	O
University	O
Medical	O
Center	O
Network	O
from	O
2012	O
to	O
2015	O
.	O
Mr.	O
Ludwig	O
received	O
a	O
B.A.	O
degree	O
in	O
economics	O
and	O
accounting	O
from	O
The	O
College	O
of	O
the	O
Holy	O
Cross	O
and	O
a	O
M.B.A.	O
degree	O
from	O
Columbia	O
University	O
.	O
Stephen	O
P.	O
MacMillan	O
Stephen	O
P.	O
MacMillan	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2015	O
.	O
He	O
is	O
currently	O
the	O
Chairman	O
,	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
a	O
position	O
he	O
has	O
held	O
since	O
June	O
2015	O
,	O
and	O
he	O
served	O
as	O
President	O
and	O
CEO	O
of	O
Hologic	O
,	O
Inc.	O
,	O
since	O
December	O
2013	O
.	O
Prior	O
to	O
assuming	O
his	O
role	O
with	O
Hologic	O
,	O
Mr.	O
MacMillan	O
was	O
the	O
Chief	O
Executive	O
Officer	O
of	O
sBioMed	O
,	O
LLC	O
,	O
a	O
medical	O
research	O
company	O
,	O
from	O
October	O
2012	O
to	O
December	O
2013	O
.	O
From	O
2003	O
to	O
2012	O
,	O
Mr.	O
MacMillan	O
served	O
in	O
various	O
roles	O
at	O
Stryker	O
Corporation	O
,	O
including	O
Chief	O
Operating	O
Officer	O
from	O
June	O
2003	O
to	O
January	O
2005	O
,	O
President	O
from	O
June	O
2003	O
to	O
February	O
2012	O
,	O
Chief	O
Executive	O
Officer	O
from	O
January	O
2005	O
to	O
February	O
2012	O
and	O
Chairman	O
from	O
January	O
2010	O
to	O
February	O
2012	O
.	O
Prior	O
to	O
2003	O
,	O
Mr.	O
MacMillan	O
was	O
a	O
senior	O
executive	O
with	O
Pharmacia	O
Corporation	O
where	O
he	O
oversaw	O
five	O
global	O
businesses	O
.	O
Prior	O
to	O
joining	O
Pharmacia	O
,	O
Mr.	O
MacMillan	O
spent	O
11	O
years	O
with	O
Johnson	O
&	O
Johnson	O
in	O
a	O
variety	O
of	O
senior	O
roles	O
both	O
in	O
the	O
U.S.	O
and	O
Europe	O
,	O
including	O
President	O
of	O
the	O
joint	O
venture	O
between	O
Johnson	O
&	O
Johnson	O
and	O
Merck	O
.	O
Mr.	O
MacMillan	O
began	O
his	O
career	O
with	O
Procter	O
and	O
Gamble	O
in	O
1985	O
.	O
Additionally	O
,	O
Mr.	O
MacMillan	O
served	O
on	O
the	O
board	O
of	O
directors	O
of	O
Texas	O
Instruments	O
Inc.	O
from	O
2008	O
to	O
2012	O
and	O
Alere	O
,	O
Inc.	O
from	O
2013	O
to	O
2015	O
.	O
Mr.	O
MacMillan	O
received	O
a	O
Bachelor	O
of	O
Arts	O
degree	O
in	O
Economics	O
from	O
Davidson	O
College	O
and	O
is	O
a	O
graduate	O
of	O
Harvard	O
Business	O
School	O
's	O
Advanced	O
Management	O
Program	O
.	O
Michael	O
F.	O
Mahoney	O
Michael	O
F.	O
Mahoney	O
became	O
our	O
Chairman	O
of	O
the	O
Board	O
,	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
in	O
May	O
2016	O
.	O
He	O
served	O
as	O
President	O
,	O
Chief	O
Executive	O
Officer	O
and	O
director	O
from	O
November	O
2012	O
to	O
April	O
2016	O
.	O
He	O
served	O
as	O
President	O
of	O
the	O
Company	O
from	O
October	O
2011	O
to	O
October	O
2012	O
.	O
As	O
President	O
of	O
the	O
Company	O
,	O
he	O
was	O
specifically	O
responsible	O
for	O
our	O
Cardiac	O
Rhythm	O
Management	O
and	O
Endoscopy	O
businesses	O
,	O
as	O
well	O
as	O
certain	O
corporate	O
functions	O
.	O
Prior	O
to	O
joining	O
the	O
Company	O
,	O
he	O
was	O
Worldwide	O
Chairman	O
of	O
the	O
Medical	O
Devices	O
and	O
Diagnostics	O
division	O
of	O
Johnson	O
&	O
Johnson	O
from	O
January	O
2011	O
to	O
September	O
2011	O
overseeing	O
50,000	O
employees	O
and	O
seven	O
franchises	O
.	O
Prior	O
to	O
assuming	O
this	O
position	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
Worldwide	O
Group	O
Chairman	O
of	O
Johnson	O
&	O
Johnson	O
's	O
DePuy	O
franchise	O
,	O
an	O
orthopedics	O
and	O
neurosciences	O
business	O
,	O
from	O
April	O
2007	O
through	O
January	O
2011	O
.	O
From	O
January	O
2001	O
through	O
March	O
2007	O
,	O
Mr.	O
Mahoney	O
served	O
as	O
President	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Global	O
Healthcare	O
Exchange	O
-LRB-	O
GHX	O
-RRB-	O
,	O
a	O
provider	O
of	O
supply	O
chain	O
solutions	O
and	O
services	O
that	O
brings	O
together	O
hospitals	O
,	O
manufacturers	O
,	O
distributors	O
and	O
group	O
purchasing	O
organizations	O
.	O
Mr.	O
Mahoney	O
began	O
his	O
career	O
at	O
General	O
Electric	O
Medical	O
Systems	O
,	O
where	O
he	O
spent	O
12	O
years	O
,	O
culminating	O
in	O
the	O
role	O
of	O
General	O
Manager	O
of	O
the	O
Healthcare	O
Information	O
Technology	O
business	O
.	O
He	O
currently	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Baxter	O
International	O
,	O
Inc.	O
.	O
Mr.	O
Mahoney	O
earned	O
a	O
B.B.A.	O
in	O
Finance	O
from	O
the	O
University	O
of	O
Iowa	O
and	O
a	O
M.B.A.	O
from	O
Wake	O
Forest	O
University	O
.	O
David	O
J.	O
Roux	O
David	O
J.	O
Roux	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
January	O
2014	O
.	O
Mr.	O
Roux	O
is	O
a	O
co-founder	O
and	O
Senior	O
Director	O
of	O
Silver	O
Lake	O
,	O
a	O
private	O
equity	O
firm	O
focused	O
on	O
technology	O
investing	O
.	O
He	O
was	O
formerly	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Liberate	O
Technologies	O
,	O
Executive	O
Vice	O
President	O
at	O
Oracle	O
Corporation	O
and	O
Senior	O
Vice	O
President	O
at	O
Lotus	O
Development	O
.	O
Mr.	O
Roux	O
served	O
as	O
a	O
member	O
of	O
the	O
boards	O
of	O
directors	O
of	O
Avaya	O
Inc.	O
from	O
December	O
2008	O
until	O
December	O
2012	O
,	O
Avaya	O
Holdings	O
Corp.	O
from	O
January	O
2007	O
until	O
December	O
2012	O
,	O
Serena	O
Software	O
,	O
Inc.	O
from	O
March	O
2006	O
until	O
March	O
2011	O
and	O
Intelsat	O
S.A.	O
from	O
May	O
2010	O
until	O
January	O
2012	O
.	O
Mr.	O
Roux	O
holds	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School	O
and	O
an	O
M.	O
Phil	O
.	O
from	O
King	O
's	O
College	O
,	O
Cambridge	O
University	O
.	O
He	O
is	O
a	O
graduate	O
of	O
Harvard	O
College	O
.	O
John	O
E.	O
Sununu	O
John	O
E.	O
Sununu	O
has	O
been	O
a	O
director	O
since	O
April	O
2009	O
.	O
From	O
2003	O
to	O
2009	O
,	O
Senator	O
Sununu	O
served	O
as	O
a	O
U.S.	O
Senator	O
from	O
New	O
Hampshire	O
.	O
He	O
was	O
a	O
member	O
of	O
the	O
Committees	O
on	O
Banking	O
,	O
Commerce	O
,	O
Finance	O
and	O
Foreign	O
Relations	O
,	O
and	O
he	O
was	O
appointed	O
the	O
Congressional	O
Representative	O
to	O
the	O
United	O
Nations	O
General	O
Assembly	O
.	O
Before	O
his	O
election	O
to	O
the	O
Senate	O
,	O
Senator	O
Sununu	O
served	O
three	O
terms	O
as	O
a	O
Member	O
of	O
the	O
U.S.	O
House	O
of	O
Representatives	O
from	O
New	O
Hampshire	O
's	O
1st	O
District	O
from	O
1996	O
to	O
2002	O
.	O
He	O
was	O
Vice	O
Chairman	O
of	O
the	O
Budget	O
Committee	O
and	O
a	O
member	O
of	O
the	O
Appropriations	O
Committee	O
.	O
During	O
his	O
twelve	O
years	O
in	O
Congress	O
,	O
he	O
drafted	O
and	O
helped	O
pass	O
several	O
important	O
pieces	O
of	O
legislation	O
,	O
including	O
the	O
Internet	O
Tax	O
Freedom	O
Act	O
,	O
the	O
Survivors	O
Benefit	O
Act	O
and	O
the	O
New	O
England	O
Wilderness	O
Act	O
.	O
Prior	O
to	O
serving	O
in	O
Congress	O
,	O
Senator	O
Sununu	O
served	O
as	O
Chief	O
Financial	O
Officer	O
for	O
Teletrol	O
Systems	O
,	O
a	O
manufacturer	O
of	O
building	O
control	O
systems	O
.	O
He	O
serves	O
on	O
the	O
board	O
of	O
directors	O
of	O
Time	O
Warner	O
Cable	O
,	O
Inc.	O
.	O
He	O
holds	O
B.S.	O
and	O
M.S.	O
degrees	O
in	O
Mechanical	O
Engineering	O
from	O
the	O
Massachusetts	O
Institute	O
of	O
Technology	O
and	O
an	O
M.B.A.	O
from	O
Harvard	O
Business	O
School.	O
,	O
Ellen	O
M.	O
Zane	O
Ellen	O
M.	O
Zane	O
,	O
has	O
been	O
a	O
director	O
of	O
Boston	O
Scientific	O
since	O
April	O
2016	O
.	O
Ms.	O
Zane	O
is	O
CEO	O
Emeritus	O
and	O
Vice	O
Chair	O
of	O
the	O
board	O
of	O
trustees	O
at	O
Tufts	O
Medical	O
Center	O
&	O
Floating	O
Hospital	O
for	O
Children	O
,	O
and	O
from	O
2004	O
to	O
2011	O
,	O
she	O
served	O
as	O
its	O
President	O
and	O
Chief	O
Executive	O
Officer	O
.	O
From	O
May	O
1994	O
to	O
January	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Network	O
President	O
for	O
Partners	O
Healthcare	O
System	O
,	O
a	O
physician/hospital	O
network	O
sponsored	O
by	O
the	O
Harvard	O
affiliated	O
Massachusetts	O
General	O
Hospital	O
and	O
Brigham	O
and	O
Women	O
's	O
Hospital	O
.	O
Prior	O
to	O
2004	O
,	O
Ms.	O
Zane	O
served	O
as	O
Chief	O
Executive	O
Officer	O
of	O
Quincy	O
Hospital	O
in	O
Quincy	O
,	O
Massachusetts	O
.	O
Ms.	O
Zane	O
is	O
also	O
currently	O
a	O
member	O
of	O
the	O
board	O
of	O
directors	O
at	O
Brooks	O
Automation	O
,	O
a	O
publicly	O
traded	O
global	O
provider	O
of	O
automation	O
,	O
vacuum	O
and	O
instrumentation	O
solutions	O
,	O
Parexel	O
International	O
Corporation	O
,	O
a	O
publicly	O
traded	O
global	O
bio-pharmaceutical	O
services	O
company	O
and	O
Press	O
Ganey	O
,	O
a	O
publicly	O
traded	O
preeminent	O
provider	O
of	O
patient	O
experience	O
measurement	O
and	O
data	O
in	O
acute	O
hospital	O
settings	O
and	O
ambulatory	O
settings	O
,	O
Century	O
Capital	O
Management	O
,	O
LLC	O
,	O
a	O
private	O
mutual	O
fund	O
company	O
,	O
Fiduciary	O
Trust	O
Company	O
,	O
a	O
privately	O
owned	O
wealth	O
management	O
company	O
and	O
AgNovos	O
Healthcare	O
,	O
LLC	O
a	O
privately	O
held	O
medical	O
device	O
company	O
,	O
focused	O
on	O
bone	O
health	O
.	O
Ms.	O
Zane	O
previously	O
served	O
as	O
a	O
director	O
of	O
Lincare	O
Holdings	O
Inc.	O
until	O
it	O
was	O
acquired	O
in	O
August	O
2012	O
.	O
Ms.	O
Zane	O
holds	O
a	O
Professional	O
Director	O
Certification	O
from	O
the	O
American	O
College	O
of	O
Corporate	O
Directors	O
.	O
Ms.	O
Zane	O
earned	O
her	O
B.A.	O
from	O
George	O
Washington	O
University	O
and	O
her	O
M.A.	O
from	O
Catholic	O
University	O
of	O
America	O
,	O
both	O
in	O
Audiology	O
and	O
Speech-Language	O
Pathology.	O
,	O
Top	O
,	O
http://www.bostonscientific.com/en-US/about-us/executive-committee.html	O
